Bill Ackman

Bill Ackman Articles

If there is one thing investors know about billionaire investor Bill Ackman, he doesn’t do half measures. The hedge fund manager likes to make big bets on companies and his Pershing Square Capital...
Bill Ackman made news recently when Fortune reported that he might play a part in Elon Musk and Vivek Ramaswamy’s Department of Government Efficiency, or DOGE, the committee tasked with cutting...
Bill Ackman is probably best known as the founder and CEO of Pershing Square Capital Management, a leading hedge fund managing more than $10 billion in assets for its clients. Ackman has long touted...
There are many billionaires who style themselves as Buffett-esque investors. They may not quite be value investors in the vein of Graham and Dodd, Warren Buffett’s influential mentors, but they do...
Hedge fund operator Bill Ackman likes to make big bets. His Pershing Square Capital Management fund has $10.4 billion in assets under management and it is concentrated in just nine positions. These...
Some of the biggest insider buying since the Thanksgiving holiday has come from repeat buyers, including Bill Ackman, who continues to build his stake in a real estate firm.
Notable insider buying in the past week included biotech and energy companies, including some that have just gone public. Also, renowned hedge fund manager Bill Ackman continues building a stake in a...
Exxon Mobil and another energy giant saw huge insider buys this week, while Bill Ackman continued to build his stake in Howard Hughes.
Bill Ackman’s Pershing Square Tontine special purpose acquisition company entered the market on Tuesday above its original pricing.
Pershing Square Tontine Holdings has filed with the SEC regarding its initial public offering.
Herbalife has been more than a controversial stock over the past three years or more. Short seller and activist investor Bill Ackman had roughly a $1 billion bet against this company and has been a...
Carl Icahn believes that Herbalife might be better off as a privately held firm and he has weighed the possibility of launching a tender offer for it.
Although some analysts have become less negative and upgraded to a more neutral view on Valeant Pharmaceuticals, Morgan Stanley's is a true call to buy the stock.
Herbalife is treating this settlement as a victory. The question now is whether it will begin to aggressively go after Bill Ackman for calling Herbalife a pyramid scheme.
Insiders looking to sell shares are starting to emerge from the sidelines as quiet periods are ending, including activist investor Bill Ackman.